Collegium Pharmaceutical (COLL) Capital Expenditures (2015 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Capital Expenditures of $207000.0 for Q1 2026, down 74.06% year-over-year from $798000.0 in Q1 2025, and up 128.28% quarter-over-quarter from -$732000.0 in Q4 2025.
Collegium Pharmaceutical (COLL) Capital Expenditures (2015 - 2026) Analysis & Trends
Collegium Pharmaceutical's Capital Expenditures history runs 12 years deep, the most recent figure standing at $207000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 74.06% year-over-year to $207000.0; the TTM figure through Mar 2026 stood at -$272000.0 (down 165.54% YoY), while the FY2025 annual figure was $319000.0, up 72.43% from the prior year.
- Capital Expenditures for Q1 2026 stood at $207000.0, up from -$732000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $940000.0 in Q4 2022, with the low at -$897000.0 in Q4 2024.
- The 5-year median for Capital Expenditures is $164000.0 (2023), against an average of $164352.9.
- Peak annual rise in Capital Expenditures reached 1256.92% in 2024, while the deepest fall reached 757.14% in 2024.
- Collegium Pharmaceutical's Capital Expenditures stood at $940000.0 in 2022, then plunged by 82.55% to $164000.0 in 2023, then tumbled by 646.95% to -$897000.0 in 2024, then rose by 18.39% to -$732000.0 in 2025, then surged by 128.28% to $207000.0 in 2026.
- Business Quant data shows COLL's Capital Expenditures at $207000.0 in Q1 2026, -$732000.0 in Q4 2025, and $188000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 894.62 Mn | 745.30 Mn | 110.29 Mn | 496,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 496,000.00 |
| Jun 30, 2026 | 496,000.00 |
| Mar 31, 2026 | 207,000.00 |
| Mar 31, 2026 | 207,000.00 |
| Dec 31, 2025 | -732,000.00 |
| Dec 31, 2025 | -732,000.00 |
| Sep 30, 2025 | 188,000.00 |
| Sep 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 65,000.00 |
| Mar 31, 2025 | 798,000.00 |
| Mar 31, 2025 | 798,000.00 |
| Dec 31, 2024 | -897,000.00 |
| Dec 31, 2024 | -897,000.00 |
| Sep 30, 2024 | 882,000.00 |
| Sep 30, 2024 | 882,000.00 |
| Jun 30, 2024 | -368,000.00 |
| Jun 30, 2024 | -368,000.00 |
| Mar 31, 2024 | 568,000.00 |
| Mar 31, 2024 | 568,000.00 |